A phase 3 double-blind randomized (CONSORT-compliant) study of azilsartan medoxomil compared to valsartan in Chinese patients with essential hypertension
暂无分享,去创建一个
Q. Lv | M. Long | Wei Zhou | Yong-xu Xia | Zeqi Zheng | Jing-tao Wu | Jun Zhang | Xin Du | Changsheng Ma | Z. Yao | Zhan-quan Li | M. Hisada | Jiahui Wu | Chengchun Tang | Jingtao Wu | Zhuhua Yao